Catalent Completes Facility Expansion in Italy

US-based Catalent Pharma Solutions has completed the expansion of its facility in Aprilia, Italy, which was successfully inspected by the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA).

This expansion offers services from product conceptualization to formulation, development, production and packaging for prescription and OTC products. It also enhances European quality and analytical capabilities that include services such as market registration, analytical testing and market release by qualified persons.

Stefano Arena, general manager of Catalent’s Aprilia site, said,"Expanding our drug delivery capabilities and expertise reinforces Catalent Aprilia’s position as a leading integrated development and delivery facility in Southern Europe.”